A prescription answers only part of the question.

Ask about the person and the product separately

US federal law, as it stood on September 26, 2026, required prescription medicines to be ordered by a practitioner licensed to prescribe them.

A compounded medicine still lacks FDA (the US Food and Drug Administration) approval, even when it comes with a prescription.

• Who is making the prescribing decision?
• What is the exact product being prescribed?
• If it is compounded, why is that preparation being proposed for me?
• Who will make it, and who will explain the label?

The state still matters

A general statement about remote visits does not settle the rules for a particular state.

In guidance reviewed September 26, 2026, HHS, the US Department of Health and Human Services, says professionals must meet licensing rules where they are and be permitted to practise where the patient is.

Ask the service which licence permits your care in that state. If it relies on an exception, ask it to name the exception and confirm it with that state’s medical board.

Give the service the state you will be in for the encounter, including during travel. Ask which licence or other permission covers care there.

Keep the answers together

Put the prescriber’s full name, the product name and the dispensing pharmacy’s name in the same set of notes. Then check the relevant records.